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Background: Although silver nanoparticles are currently used in more than 400 consumer products, it is not clear
to what extent they induce adverse effects after inhalation during production and use. In this study, we determined
the lung burden, tissue distribution, and the induction and recovery of adverse effects after short-term inhalation
exposure to 15 nm and 410 nm silver nanoparticles.
Methods: Rats were nose-only exposed to clean air, 15 nm silver nanoparticles (179 μg/m3) or 410 nm silver particles
(167 μg/m3) 6 hours per day, for four consecutive days. Tissue distribution and the induction of pulmonary toxicity
were determined at 24 hours and 7 days after exposure and compared with the internal alveolar dose. Presence of
silver nanoparticles in lung cells was visualized by transmission electron microscopy (TEM).
Results: Exposure to 15 nm silver nanoparticles induced moderate pulmonary toxicity compared to the controls,
indicated by a 175-fold increased influx of neutrophils in the lungs, a doubling of cellular damage markers in the lungs,
a 5-fold increase in pro-inflammatory cytokines, and a 1.5-fold increase in total glutathione at 24 hours after exposure.
All the observed effects disappeared at 7 days after exposure. No effects were observed after exposure to 410 nm silver
particles. The internal alveolar mass dose of the 15 nm nanoparticles was 3.5 times higher compared to the 410 nm
particles, which equals to a 66,000 times higher particle number. TEM analysis revealed 15 nm nanoparticles in
vesicles and nuclei of lung cells, which were decreased in size to <5 nm at 24 hours after exposure. This
demonstrates substantial dissolution of the silver nanoparticles.
Conclusion: The results show a clear size-dependent effect after inhalation of similar mass concentrations of
15 nm and 410 nm silver (nano)particles. This can be partially explained by the difference in the internal alveolar dose
between the 15 nm and 410 nm silver (nano)particles as well as by a difference in the release rate of silver ions.
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Nanomaterials are used in a rapidly increasing number
of products including consumer products [1]. However,
there are concerns these nanomaterials might introduce
health risks upon occupational and consumer exposure.
Although many nanomaterials are produced, handled
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unless otherwise stated.energetic processes, such as vortexing, weighing, sonic-
ation, mixing and blending [2]. In addition, nanomater-
ials may be released from their matrix during its use.
Therefore, inhalation is considered a relevant route of
exposure [2,3]. Currently, silver nanoparticles are the
most common nanoparticles mentioned in product de-
scriptions. According to the Nanotechnology Consumer
Products Inventory, silver nanoparticles are currently
claimed to be used in more than 400 consumer products
[1]. Silver nanoparticles have antimicrobial activity and
are used in food packaging material, food supplements,
odour-preventing textiles, cosmetics, kitchen utensils,ral Ltd. This is an Open Access article distributed under the terms of the Creative
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Silver (nano)particles and released ions exert antimicrobial
properties by binding to sulphur- and phosphorous-
containing biomolecules such as proteins and DNA,
thereby potentially also causing damage to mammalian
cells [5-9]. Besides worker exposure, the extensive use of
silver nanoparticles in products might also lead to con-
sumer exposure by inhalation of the silver nanoparticles
that are used in spray applications. Although silver nano-
particles are currently claimed to be used in many prod-
ucts, it is not clear to what extend they induce adverse
effects after inhalation during production and use.
Silver nanoparticles have been studied in several in vivo
inhalation studies showing diverse outcomes. Some stud-
ies showed no induction of adverse effects [10,11], while
other studies reported adverse effects varying from a min-
imal inflammatory response to the presence of inflamma-
tory lesions in the lungs [12-15]. Regarding the tissue
distribution of the silver nanoparticles, some studies re-
port a dose-dependent increase in the silver concentration
in the lungs and in the liver [11,13,15]. Two of these stud-
ies report a rather high amount of silver detected in the
brain and the olfactory bulb [11,15], causing concerns that
silver nanoparticles might induce toxicity in the brain.
The before mentioned inhalation studies show that sil-
ver nanoparticles can induce pulmonary inflammation
and can decrease lung function, depending on the ex-
posure time and dosage [10-15]. However, all of these
studies focused on a single particle size. The previous
studies did not take particle size and surface area into
account as explaining variable, whereas these affect the
internal dose and the interaction probability with cells.
For particles to induce pulmonary inflammation, they
must deposit in the alveolar region. The deposition of
(nano)particles depends mostly on their (agglomerate)
size. Nanoparticles with a primary or agglomerate par-
ticle size between 10 and 100 nm will deposit more effi-
ciently in the alveolar region compared to particles with
an agglomerate particle size between 0.1 and 1 μm
[16-20]. At a similar mass based exposure dose, particles
of different sizes will have a different deposition pattern
in the lungs, and the deposited dose in the alveoli ultim-
ately determines the extent of the pulmonary toxic ef-
fects. The previous studies did not link the deposited
dose in the alveoli to the observed effects [10-15].
Until now, the formulation in which silver nanoparti-
cles induce toxicity remains unclear. The effects might
be caused by the silver nanoparticles itself, the released
silver ions, or a combination of both. Next to this, it re-
mains unclear to what extend the geometric size of silver
particles affect the induction of pulmonary inflamma-
tion. Since particle size is the most important particle
characteristic that determines the deposited dose in the
lungs and is of influence on the dissolution rate of silvernanoparticles, the aim of this study is to investigate the
influence of particle size on pulmonary toxicity of silver
nanoparticles. We hypothesize that small silver nanopar-
ticles will induce more prominent pulmonary toxicity
compared to larger silver particles because of the larger
deposited dose in the alveoli and the higher dissolution
rate. In the present study, we tested the effects of a simi-
lar mass exposure concentration of 15 nm and 410 nm
silver (nano)particles after short-term nose-only inhal-
ation exposure. The total lung burden was measured
and used together with the exposure measurements as
an input for the multiple path particle dosimetry
(MPPD) model to estimate the alveolar dose. Transmis-
sion electron microscopy (TEM) was used to localize sil-
ver particles in the lung tissue and tissue distribution was
measured to determine any differences in the kinetics of
the silver particles. To determine the toxicity induced by
15 nm and 410 nm silver (nano)particles, body weight,
total blood cell counts, inflammatory and cell damage
markers in the bronchoalveolar lavage fluid (BALF) and
histology of the lungs were analysed. All endpoints were
determined at 24 hours and 7 days after the last exposure
to investigate the possible recovery of adverse effects.
Results
Nanoparticle characteristics
The particle characteristics are summarized in Table 1 and
shown in Additional file 1: Figure S1. The silver nanoparti-
cles had a count median diameter of 15 nm (Figure 1) and
the exposed dosage was 179 μg/m3 air. For the larger silver
particles, the 200 nm primary silver particles agglomerated
to a count median diameter of 410 nm (Figure 1) and the
exposed dosage was 167 μg/m3 air. While the mass dosage
was similar for both particle groups, the particle number
dosage was 3.8 × 106 particles per cm3 for the 15 nm nano-
particles and 2.0 × 104 particles per cm3 for the 410 nm
particles.
Experimental design
Since male rats showed more sensitivity towards induc-
tion of pulmonary inflammation compared to female
rats after 90 days inhalation exposure [13,14], we chose
to expose male rats. The rats were nose-only exposed
for 6 hours per day, 4 consecutive days to fresh air,
15 nm silver nanoparticles or 410 nm silver particles, 12
rats per exposure group. Of each exposure group, 6 rats
were sacrificed 24 hours after exposure and the other 6
rats were sacrificed 7 days after exposure.
Quantification of silver in tissues by high resolution
inductively coupled plasma mass spectrometry (HR-ICP-MS)
The presence of silver was measured with HR-ICP-MS
in the lungs, liver, spleen, kidneys, brain, testis and lung-
associated lymph nodes. Of these tissues, silver was
Table 1 Nanoparticle characteristics
Agglomerate size [nm] Mass [μg/m3] Particle number [#/cm3] Surface area [nm2/cm3]
15.3 (1.26) 179 (107–252) 3.8 × 106 (2.6 - 5.0) 6.72 × 109 (3.97-9.49)
410 (1.43) 167 (147–187) 2.0 × 104 (0.43 - 3.7) 2.33 × 108 (0.28-2.61)
Particle size is given as count median diameter (CMD) with the geometric standard deviation (GSD). Mass, particle number and surface area shown as mean with
a 95% confidence interval.
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after exposure, the lungs of the rats exposed to 15 nm
nanoparticles contained 3.4 μg silver per gram lung,
whereas the lungs of the rats exposed to 410 nm parti-
cles contained 6.0 μg silver per gram lung. This equals a
total lung deposit (TLD) of 5.5 μg of the 15 nm and
8.5 μg of the 410 nm silver particles, respectively. Be-
cause the silver nanoparticles are spherical, we could use
these measurements to estimate the number of silver
nanoparticles deposited in the lungs. A total lung
capacity (TLC) of 13.7 ml [16] was used that results in
2.0 × 107 particles per mm3 of 15 nm nanoparticles and
1.6 × 103 particles per mm3 of 410 nm particles in the
lungs. In the lung-associated lymph nodes, silver could
be detected in one animal exposed to 15 nm silver nano-
particles. In the other animals, the level of silver in the
lymph nodes was below the detection limit. In addition,
the level of silver in the other tested tissues (spleen, kid-
neys, testis, brain) was below the detection limit of
0.01 μg/g tissue. At 7 days after exposure, the silver con-
tent in the lungs decreased to 1.3 μg/g tissue (2.1 μg
TLD) for the rats exposed to 15 nm silver nanoparticles
and 3.9 μg/g tissue (5.9 μg TLD) for the rats exposed to
410 nm silver particles. In the liver, silver was detected
in the rats exposed to 15 nm silver nanoparticles at a
level of 0.06 μg/g tissue (0.53 μg total) at 24 hours after
exposure and 0.01 μg/g tissue (0.095 μg total) at 7 days
after exposure, indicating removal of silver. No silverA
Figure 1 Scanning electron microscopy (SEM) pictures of the 15 nm silv
polycarbonate filters with 0.22 μm pores (Pictures are made in back-scawas detected in the liver of rats exposed to 410 nm silver
particles at either time points.
Estimated deposited dose in lungs using Multiple Path
Particle Dosimetry Model (MPPD model)
According to the MPPD model, the total deposited frac-
tion in the lungs is similar for both particle sizes [16] at
0.69 for the 15 nm nanoparticles, and 0.67 for the
410 nm particles. However, according to our HR-ICP-
MS measurements, the TLD was 5.5 μg for the 15 nm
nanoparticles and 8.5 μg for the 410 nm particles at
24 hours after exposure. The lower silver content in the
lungs of the animals exposed to 15 nm particles might
be explained by clearance of silver in the time between
the end of the exposure and the sacrifice and after each
day of exposure. The deposition in the alveoli differs be-
tween the two particle sizes: the deposited fraction in
the alveoli is 0.27 for the 15 nm nanoparticles and 0.048
for the 410 nm particles [16]. Based on the HR-ICP-MS
results, we estimated the deposited mass in the alveolar
region was 2.1 μg for the 15 nm nanoparticles and
0.6 μg for the 410 nm particles at 24 hours after expos-
ure, which equals 7.9 × 106 particles per mm3 for the
15 nm nanoparticles and 118 particles per mm3 for the
410 nm particles. Based on mass, the deposited dose in
the alveoli was 3.5 times higher in the animals exposed
to 15 nm silver nanoparticles compared to the animals
exposed to 410 nm silver particles at 24 hours afterB
er nanoparticles (A) and the 410 nm silver particles (B) captured on
tter mode).
Figure 2 Amount of silver detected in the lungs and liver by HR-ICP-MS at 24 hours and 7 days after exposure. In the liver, silver could
be detected in the animals exposed to 15 nm silver nanoparticles and not in the animals exposed to 410 nm silver particles. For both particle
sizes, the amount of silver in the lungs at 7 days after exposure was significantly lower compared to 24 hours after exposure.
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in the alveoli was 66,000 times higher for the 15 nm
compared to the 410 nm particle group.
Electron microscopy of the lung
As reported above, the estimated number of silver parti-
cles in the alveoli was 7.8 × 106 particles per mm3 for
the 15 nm nanoparticles and 118 particles per mm3 for
the 410 nm particles. The ultrathin TEM coupes are
70 nm thick; therefore, the expected number of particles
per mm2 is 8 for the 410 nm particles, which may be too
few to be detected. In contrast, for the 15 nm nanoparti-
cles, the expected number is much higher: 5.5 × 105
nanoparticles per mm2. Despite of this relatively high
number neither 15 nor 410 nm silver particles could be
detected in TEM section of the in epon embedded lung
tissue.
Dissolution of silver nanoparticles is known to occur
and will clearly result in a decrease in the size of the sil-
ver nanoparticles. Silver nanoparticles below 5 nm are
difficult to detect in a biological sample by EM. There-
fore, we employed the silver enhancement technique, a
well-known approach to detect for instance 1 nm gold
particles, normally not detectable in a biological sample
by TEM. Silver enhancement also intensifies the EM sig-
nal of the silver nanoparticles by homogenous deposition
of metallic silver on the particles surface, thereby in-
creasing the particle size of the silver nanoparticles in
the processed tissue. After silver enhancement on grids
containing ultrathin lung sections, electron dense structureswere detected by TEM in the lungs of the animals ex-
posed to 15 nm silver nanoparticles (Figure 3), whereas
they were almost absent in ultrathin lung sections of
control animals. Two different grids containing ultra-
thin lung sections of control animals and three different
grids containing ultrathin lung sections of animals ex-
posed to 15 nm silver nanoparticles were examined for
the presence of silver nanoparticles; at least 50 cell pro-
files per ultrathin section were examined. After silver
enhancement, in the lung sections of the control ani-
mals silver dots were detected in 2% of the examined
cells, whereas in the lung sections from the animals
exposed to 15 nm silver nanoparticles silver dots were
detected in 56% of the examined cells. The silver nano-
particles were both present in alveolar macrophages
and lung epithelial cells (Figure 3). The nanoparticles
were located mostly in vesicle-like structures and in
the nucleus (Figure 3). However, in some cells the sil-
ver dots seemed randomly spread. The size of these
deposits after silver enhancement was about 15 –
20 nm. This indicates that the original particle size of
the silver nanoparticles in the lung tissue, without depos-
ition of metallic silver, was smaller than 5 nm (P. van
de Plas, Aurion, Wageningen, the Netherlands; personal
communication).
Clinical examinations
Exposure to silver nanoparticles of 15 nm and silver par-
ticles of 410 nm did not induce any premature mortality.
There were no effects on animal attitude, fur, activity
Figure 3 TEM pictures of lung tissue of rats exposed to clean air (A and B) or 15 nm silver nanoparticles (C, D, E and F), afterwards
followed by silver enhancement. The pictures show the presence of silver nanoparticles in the nucleus, lamellar bodies and lysosomes of lung
cells (indicated by the red arrows) at 24 hours after exposure.
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urine production, and no effects on body weights and
organ weights throughout the study (Table 2).Hematology
In the blood, the total amount of white blood cells and
the amount of neutrophils and lymphocytes were all
Table 2 Animal weights given in grams
Group Arrival Start of exposure 24 hours after exposure 7 days after exposure
Control 187 (178 – 197) 235 (218 – 253) 232 (220 – 243) 250 (237 – 263)
15 nm Ag 188 (179 – 197) 237 (228 – 245) 231 (222 – 240) 248 (243 – 253)
410 nm Ag 187 (177 – 197) 240 (228 – 253) 234 (221 – 247) 243 (229 – 258)
Data shown as mean with a 95% confidence interval.
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nanoparticles compared to the other groups at 24 hours
after exposure (Figure 4). However, the differences were
not statistically significant. At 7 days after exposure,
there was no increase in any of the measured blood cells.
There were no increases in inflammatory blood cells in
the group exposed to 410 nm silver particles at both
time points. The level of Fibrinogen in the plasma did
not differ between the controls and the exposed groups
at both time points (data not shown).
Histopathology
The histopathology analysis showed no differences be-
tween the groups. No lesions were observed in any of
the lungs (results not shown).
Total cell counts and differential cell counts in the
bronchoalveolar lavage fluid (BALF)
The cell counts in the bronchoalveolar lavage fluid
(BALF) are shown in Figure 5. The total cell number
was increased 24 hours after exposure to 15 nm silver
nanoparticles compared to control (p = 0.063) and sig-
nificantly increased compared to the group exposed to
410 nm silver particles (p < 0.05). The increased cell
number is caused by a neutrophil influx (Figure 6). 24 hours
after exposure, there was an average of 3.95 × 105 neutro-
phils per ml cell pellet in the group exposed to 15 nm silver
nanoparticles compared to 2.3 × 103 neutrophils per mlFigure 4 Number and type of cells in the blood after exposure to 15
amount of white blood cells was slightly increased in the group exposed t
number of neutrophils and lymphocytes. The differences were not statisticpellet in the controls (p <0.01) and 2.1 × 103 neutrophils
per ml pellet in the 410 nm silver particles exposed ani-
mals (p < 0.01). In addition, the number of lymphocytes
in the BALF was increased after exposure to 15 nm sil-
ver nanoparticles (p < 0.05 compared to control, p <0.05
compared to 410 nm silver). The number of monocytes
in the BALF 24 hours after exposure was also increased:
3300 monocytes per ml pellet in the group exposed to
15 nm silver nanoparticles compared to 150 in the
controls and 0 in the group exposed to 410 nm silver
particles (p < 0.01 and p < 0.001). Remarkably, the num-
ber of macrophages in the BALF was decreased 24 hours
after exposure to 15 nm silver nanoparticles compared
to control, although not statistically significant. There
were no differences between the groups in number of
multi-nuclei macrophages. There were no eosinophils
detected in any of the exposed groups 24 hours after
exposure.
The cell counts in the BALF at 7 days after exposure
were completely different from those at 24 hours after
exposure. At 7 days after exposure, most observed ef-
fects disappeared. There were no differences in the
number of lymphocytes, macrophages and monocytes
between the exposure groups. There was a slight de-
crease in the number of neutrophils in the BALF of rats
exposed to 15 nm silver nanoparticles compared to
both control and 410 nm silver particles, although not
statistically significant.nm and 410 nm silver particles. At 24 hours after exposure, the total
o 15 nm silver nanoparticles compared to the controls as well as the
ally significant.
Figure 5 Cell counts in the BALF of rats. The group exposed to 15 nm silver particles had an increased number of total cells (p = 0.06),
neutrophils (p < 0.01), lymphocytes (p < 0.05) and monocytes (p < 0.01) compared to the control group at 24 hours after exposure. Compared to
the group exposed to 410 nm silver particles, the increased numbers of total cells (p < 0.05), neutrophils (p < 0.01), lymphocytes (p < 0.05) and
monocytes (p < 0.001) were also significant. The increased cell numbers returned to normal at 7 days after exposure.
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the cell counts were significantly different between
24 hours and 7 days after exposure, for all cell types.
Compared to 24 hours after exposure, the total cell
number, neutrophils, lymphocytes and monocytes all sig-
nificantly decreased and the number of macrophages,
multi-nuclei macrophages significantly increased at
7 days after exposure.
LDH and total protein in the BALF
The supernatant of the BALF was used to determine lac-
tate dehydrogenase (LDH) release and total protein as
markers for cell damage (Figure 7). At 24 hours after ex-
posure, the groups exposed to 15 nm silver nanoparticles
and 410 nm silver particles both showed significantly in-
creased levels of total protein in the BALF compared to
the controls (p < 0.01 and p < 0.05 respectively). TheFigure 6 Light microscopic images of cells in the broncho-alveolar lav
exposed to clean air. B. Animals exposed to 15 nm silver nanoparticles. C. A
of neutrophils in the lung fluid of the animals exposed to 15 nm silver nanlevel of LDH was doubled at 24 hours after exposure to
15 nm silver nanoparticles compared to both control
(p = 0.05) and compared to 410 nm silver particles ex-
posed animals (p < 0.05). At 7 days after exposure, the
levels of both total protein and LDH in the BALF of
the exposed animals decreased to control levels.
Pro-inflammatory cytokines in the BALF
The supernatant of the BALF was used to determine the
level of pro-inflammatory cytokines. 12 different pro-
inflammatory cytokines were selected: IL-1β, IL-6, TNF-α,
IFN-γ, IL-13, GM-CSF, MCP-1, IL-12p70, IL-18, MIP-1a,
MIP-2 and RANTES. Of these cytokines, only IL-1β,
MCP-1 and MIP-2 could be measured; all the other cyto-
kines were and stayed below or around the detection level
(Figure 8). Both IL-1β and MCP-1 were significantly in-
creased 24 hours after exposure to 15 nm silverage fluid of the rats at 24 hours after exposure. A. Animal
nimals exposed to 410 nm silver particles. There is a significant influx
oparticles.
Figure 7 The level of total protein and LDH in the supernatant of the broncho-alveolar lavage fluid. At 24 hours after exposure, both the
animals exposed to 15 nm silver particles and 410 nm silver particles showed a significant increase in the level of total protein compared to
control (p < 0.01 and p < 0.05, respectively). The total protein levels returned to normal at 7 days after exposure. The level of LDH was also significantly
increased in the animals exposed to 15 nm silver nanoparticles at 24 hours after exposure compared to the control (p < 0.05) and to the animals
exposed to 410 nm silver particles (p < 0.05).
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15 nm nanoparticles exposed group compared to 5.5 pg/ml
for the controls (p < 0.05) and 4.9 pg/ml for the 410 nm
particles exposed group (p < 0.05). In addition, the level of
MCP-1 was increased in the rats exposed to 15 nmFigure 8 Cytokine level in the broncho-alveolar lavage fluid. The anim
levels of IL-1β (p < 0.05), MCP-1 (p = 0.06) and MIP-2 (p < 0.01) in the BALF a
exposure, the levels of IL-1β (p < 0.05) and MCP-1 (p < 0.01) were also signi
particles. At 7 days after exposure, the cytokine levels returned to normal.nanoparticles at 24 hours after exposure: 382.7 pg/ml com-
pared to 61.6 pg/ml of the controls (p = 0.063) and 42.8 in
rats exposed to 410 nm silver particles (p < 0.01). The level
of MIP-2 was significantly decreased to 26.5 pg/ml after
24 hours after exposure to 15 nm silver nanoparticlesals exposed to 15 nm silver nanoparticles had significantly increased
t 24 hours exposure compared to the controls. At 24 hours after
ficantly increased compared to the animals exposed to 410 nm silver
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0.01). The changes in IL-1β, MCP-1 and MIP-2 levels at
24 hours after exposure to 15 nm silver nanoparticles re-
covered at 7 days after exposure, when no significant differ-
ences were observed in any of the cytokine levels measured
between the different exposure groups. There were no sig-
nificant differences between the group exposed to 410 nm
silver particles and the controls at both 24 hours and 7 days
after exposure.
Oxidative stress in the lungs
The levels of total glutathione, oxidized (GSSG) and re-
duced (GSH) glutathione were measured in the hom-
ogenate of the rinsed right lung of all the rats (Figure 9).
The level of total glutathione was significantly increased
at 24 hours after exposure to 15 nm silver nanoparticles
compared to the controls (p < 0.01) and compared to the
group exposed to 410 nm silver particles (p < 0.05). The
level of reduced glutathione was also significantly in-
creased at 24 hours after exposure to 15 nm silver nano-
particles compared to the controls (p < 0.01) and the
410 nm exposed group (p < 0.05), whereas the level of
oxidized glutathione was not. The ratio of GSH/GSSG
was not significantly different between any of the expos-
ure groups. 7 days after exposure, the level of total gluta-
thione and reduced glutathione in the group exposed to
15 nm silver nanoparticles returned to control levels.
Discussion
In this short-term inhalation study, silver nanoparticles
of two different sizes were tested to determine the differ-
ences in the lung deposition, tissue distribution and ad-
verse effects. Exposure to 15 nm silver nanoparticles
induced a moderate inflammatory response at 24 hours
after the end of the exposure period. All the observed ef-
fects disappeared at 7 days after exposure. The mostFigure 9 Glutathione production in the lungs of rats. At 24 hours after
nanoparticles exposed group was significantly elevated compared to the conpronounced observed effect was the influx of neutro-
phils at 24 hours after exposure to 15 nm silver nano-
particles, which was about 175 times larger compared to
the controls. In addition, we found release of pro-
inflammatory cytokines, an increase in total glutathione
and the presence of silver nanoparticles inside lung cells.
In contrast, the 410 nm particles induced none of these
effects in the lung, clearly demonstrating a particle size
dependent difference in the induction of pulmonary
inflammation.
There are two main reasons to explain the noted dif-
ferences in effects by the two silver particles. First, the
differences in effects may be attributed to the differences
in lung deposition of the smaller versus the larger silver
particles. The total lung deposit as measured by HR-
ICP-MS was 5.5 μg for the 15 nm silver nanoparticles
and 8.5 μg for the 410 nm silver particles at 24 hours
after the end of the exposure period. According to the
MPPD model, the fraction that reaches the alveoli is
about 5.5 times higher for the 15 nm nanoparticles com-
pared to the 410 nm particles. Based on the HR-ICP-MS
results we estimated the amount of 15 nm silver nano-
particles present in the alveoli was 7.9 × 106 particles
per mm3 (2.1 μg mass or 5.8 × 1012 nm2/cm3 surface
area) and the number of 410 nm silver particles was 118
particles per mm3 (0.6 μg mass or 6.2 × 1010 nm2/cm3
surface area). Therefore, the number of bioavailable
15 nm nanoparticles in the alveoli is about 66,000 times
larger compared to the 410 nm particles, resulting in a
higher interaction probability with cells.
Comparing same mass deposits of microparticles and
nanoparticles, the latter contains a much higher number
of particles that need to be cleared. In addition, the
smaller silver nanoparticles deposit deeper in the lungs
where they are less efficiently cleared compared to the lar-
ger particles that deposit more in the conducting airwaysexposure, the total glutathione production in the 15 nm silver
trols (p < 0.01) and the 410 nm silver particles exposed group (p < 0.05).
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over, the phagocytosis of nanoparticles by macrophages is
less efficient [25-27] and slower compared to microparti-
cles [28-30]. Our results, however, show a clearance from
the lungs of 62% of the 15 nm nanoparticles compared to
31% of the 410 nm particles at 7 days after exposure. The
higher clearance rate of the smaller particles might be ex-
plained by translocation from the lungs of the smaller sil-
ver nanoparticles or the released ions to the blood or
interstitium. This is further supported by the detection of
silver in the liver of animals at 24 hours after exposure to
15 nm silver nanoparticles, indicating systemic availability
of silver particles or ions. This was not detected after ex-
posure to the 410 nm silver particles.
Previous inhalation studies with nanosilver showed a
dose-dependent increase in silver concentration in the
liver [11,13,15] and even a low translocation to the brain
and olfactory bulb [11,15]. In one study, the amount of
silver in the brain and olfactory bulb was 2.2 ng/g and
6.97 ng/g, respectively, after exposure to the highest
dose tested of 61 μg/m3 [11]. In the other study, the
amount of silver in the brain and olfactory bulb was
18.63 ng/g and 30.48 ng/g at the highest dose tested of
515 μg/m3 [15]. In both studies, the tissue distribution
of silver was detected by atomic absorption spectropho-
tometer. The reported level of silver is too low to detect
with the HR-ICP-MS, which has a detection limit of
0.01 μg/g, possibly explaining why we did not detect any
silver in the brain or olfactory bulb. It should be noted
that both detection methods do not distinguish between
silver particles and silver ions.
The second reason for the observed differences in ef-
fects between the 15 nm and 410 nm silver particles is
the difference in particle dissolution. It is known that
smaller particles dissolve faster compared to larger parti-
cles because of the high surface to volume ratio [31].
Several in vitro studies determined the dissolution rate
of silver nanoparticles. In the study of Ma et al. [31], the
dissolution of silver nanoparticles ranged from 1% for
the larger particles of 80 nm to 60% for the smallest par-
ticles of 5 nm at pH 8 during three and two months in-
cubation, respectively. However, there was no constant
release of silver ions per unit of surface area, indicating
that surface area alone did not explain the dissolution of
silver nanoparticles [31]. According to this and other
studies [31-35], the dissolution of silver nanoparticles
depends on their particle size, the pH of the solution,
the ions present in the solution (e.g. sulphate, chloride
and phosphate causing precipitations with silver ions or
catalysing dissolution), aggregation state and the incuba-
tion time. Giving these in vitro results, the dissolution
rate of the 15 nm silver nanoparticles will probably be
higher compared to the 410 nm silver particles resulting
in an increased ion release. None of these studies reportcomplete dissolution of silver nanoparticles, the effects
observed after exposure to silver nanoparticles can be
induced by the released ions, the silver nanoparticles it-
self or a combination of both.
In a study of Pratsinis et al. [36], the toxicity of silver
nanoparticles in the presence of their released ions, and
the released ions alone was tested in vitro. For small sil-
ver nanoparticles with a size below 10 nm, the released
silver ions from the surface dominated the cytotoxicity
whereas for larger silver nanoparticles the interactions
with silver particles dominated the toxicity [36]. Accord-
ing to Beer et al. [37], at silver ion fractions ≤2.6% the
silver nanoparticles contribute to the observed toxicity
while at silver ion fractions ≥5.5% the silver nanoparti-
cles do not add additional toxicity in vitro [37]. In a re-
cent published study [38], oropharyngeal aspiration in
mice of 20 nm citrate-coated silver nanoparticles caused
pulmonary inflammation indicated by neutrophil influx
and the release of pro-inflammatory cytokines, whereas
110 nm citrate-coated silver particles caused a smaller
neutrophil influx, only at the highest dose tested, and no
release of pro-inflammatory cytokines. At 21 days after
exposure, the silver content in the lungs did not differ
between 20 nm and 110 nm silver particles. In addition,
for both particle sizes, there was no silver detected in
any of the other selected organs and tissues. Solubility
test showed that about 4% of the 20 nm nanoparticles
and 2% of the 110 nm particles dissolved in 24 hours.
Therefore, the authors concluded the larger pulmonary
inflammation caused by the 20 nm silver nanoparticles
is due to the higher bioavailability of silver ions. How-
ever, the effects of 20 nm silver nanoparticles were
stronger compared to the effects of silver nitrate indicat-
ing the particles itself contributed to the observed ef-
fects. In contrast to these results, the 110 nm silver
particles caused mild sub-chronic effects in the lungs at
21 days after exposure, which might be caused by a
slower and more persistent silver ions release [38]. Simi-
lar to these studies, it is likely that the release of silver
ions contributed to the observed effects after exposure
to 15 nm silver nanoparticles in the present study. To
further elucidate the mechanism of the silver nanoparti-
cle toxicity, the dissolution behaviour of silver nanoparti-
cles inside cells should be investigated in detail.
In our study, we could detect by TEM silver nanopar-
ticles in the lung tissue of rats at 24 hours after exposure
to 15 nm silver nanoparticles. At 24 hours after exposure
to 410 nm silver particles, we could not detect silver par-
ticles in the lungs because the number of particles was
too low. The detected silver nanoparticles had a particle
size of 15–20 nm after silver enhancement, indicating
their size in the lung tissue was smaller than 5 nm be-
fore enhancement. In combination with the literature on
the dissolution of silver nanoparticles, these EM results
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partially dissolved after deposition resulting in a decrease
in particle size and the release of silver ions. The dissol-
ution might occur extra-cellular in the lung lining fluid
and intra-cellular in vesicles in epithelial cells or macro-
phages. Besides the release of silver ions, we believe the
silver nanoparticles itself may also have contributed to
the observed effects because the TEM images show the
presence of silver nanoparticles inside lung cells. The
15 nm silver nanoparticles in our study dissolved over
time resulting on the one hand in the release of toxic sil-
ver ions and on the other hand in a decrease in particle
size to <5 nm which gives the particles the opportunity
to pass the cellular membranes and the nuclear pores.
Previous studies report that particles smaller than 5 nm
possibly can pass the nuclear pores [39], while particles
of 20 nm do not reach the nucleus and could be de-
tected in vesicles and lamellar bodies in vitro [40]. Once
inside the cells and eventually inside the nucleus, silver
nanoparticles are a continued source of ion release, lead-
ing to more damage compared to silver ions released
from silver nitrate [41]. The intracellular ion release has
been reported previously as the Trojan-horse type mech-
anism [42,43]; nanoparticles can more easily enter the
cells compared to the ions itself. The higher dissolution
rate, in combination with the higher alveolar deposition
of the 15 nm nanoparticles, might explain why the
15 nm nanoparticles caused toxicity and the 410 nm
particles did not. Based on the results of the present
study, it is not possible to quantify how much of the ob-
served effects can be attributed to the difference in al-
veolar deposition and how much of the effects can be
attributed to cellular uptake and ion release.
Findings of particle size related pulmonary inflamma-
tion are not limited to silver nanoparticles. Other inhal-
ation studies with titanium dioxide, carbonaceous, nickel
oxide, zinc oxide, ferric oxide, aluminium oxyhydroxide,
quartz and cerium oxide particles also focused on the in-
fluence of particle size on the induction of pulmonary
inflammation [27,44-52]. Indeed, several studies report
that smaller nanoparticles caused a greater inflammatory
response compared to larger particles when the same
mass dosage was administered [27,44-48]. However, al-
though particle size will affect the site and amount of
deposited material, it seems that the local dose alone
cannot explain the differences in toxicity. Solubility will
at least be one of the other variables in an equation that
would allow predicting adverse effects of nanoparticles
after inhalation.
Conclusion
The results of the present short-term inhalation study of
uncoated silver particles indicate that particle size is an
important characteristic that determines the inductionof pulmonary inflammation. Exposure to 15 nm silver
nanoparticles induced moderate pulmonary inflamma-
tion at 24 hours after exposure, whereas 410 nm silver
particles did not. The lung deposition of the 410 nm sil-
ver particles was mainly in the upper airways; the num-
ber of particles deposited in the alveoli was calculated to
be 66,000 times higher for the 15 nm silver nanoparti-
cles. TEM analysis showed the presence of silver nano-
particles in lung cells that were decreased in particle
size, demonstrating the in vivo dissolution of silver
nanoparticles. Altogether, these findings strongly suggest
that size-related silver nanoparticle induced pulmonary
inflammation is a consequence of both size related lung
deposition and dissolution rate.Methods
Test material and characterization
The test atmosphere was produced by mixing silver
nanoparticles with HEPA filtered and conditioned (50%
RH, 21°C) compressed air. Depending on the target par-
ticle size, one of two types of particle generators was
used. The silver nanoparticles were produced by a Palas
GFG 1000 (Palas GmbH, Karlsruhe, Germany) spark
generator fitted with silver tipped copper electrodes. To
generate the 15 nm nanoparticles the output of the gen-
erator was immediately diluted in conditioned air. Oxy-
gen was added to the dilution air to compensate for the
argon flow from the Palas, a final concentration of 20%
oxygen in the airflow was maintained. The particle num-
ber concentration was controlled by setting the Palas
spark frequency. The final condition of the aerosol (55%
RH, 21°C) was set by adjusting the relative humidity of
the mixing air (Figure 10). 200 nm silver particles were
purchased by NanoComposix, inc. San Diego, USA. The
200 nm silver particles were polyvinylpyrrolidone (PVP)-
coated and supplied in solution of 1 mg/ml in MilliQ
water. The silver particle solution was forced through a
small nozzle of a Schlick spray nozzle where it was
broken up in small droplets (nebulized) by compressed
air. The flow of the solution was controlled using a
20 ml Terumo syringe and a syringe pump (TSE model
540200, Bad homburg, Germany). The nebulized flow
was mixed with compressed air in a heated mixing tube.
After mixing and drying, the aerosol passed through a
tube oven (700°C) to fuse the aggregates into a single
particle. The heat of the oven removed the PVP-coating
of the silver particles. After the oven, the aerosol diluted
further with conditioned air and was allowed to cool.
The mass concentration was controlled by adjusting the
syringe pump motor speed and thus the flow of the solu-
tion. The final condition of the aerosol (55% RH, 21°C)
was set by adjusting the relative humidity of the final
mixing air (Figure 11).
Figure 10 Palas spark generator setup for the nose-only exposure to 15 nm silver nanoparticles. The silver nanoparticles are generated by
the Palas spark generator and subsequently mixed with conditioned air and oxygen. Particle size, number and mass are continuously monitored.
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performed during the exposure. In the main flow up-
stream of the nose only unit particle mass concentration,
number concentration, and particle size distribution
were measured. The particle mass concentration was de-
termined by time aggregated gravimetric with Teflon
R2PJ047 filter (Pall corp., Ann Arbor MI, USA) and by
tapered element oscillating microbalance (TEOM)
series1400 (Rupprecht & Patashnick, New York, USA).
The particle number concentration was measured over
time by a condensation particle counter (CPC) 3022
(TSI inc., St Paul MN, USA). Particle size distribution
was monitored over time by an OPS 3330 (TSI inc., St
Paul MN, USA), a scanning mobility particle sizer
(SMPS) 3080 with 3085 Nano DMA (TSI inc., St Paul MN,
USA) and a MOI Model No. 110 (MSP corp, Minneapolis
MN, USA). Temperature and relative humidity were deter-
mined by a Vaisala M170 (Vaisala Oyj, Helsinki, Finland).
The particle size was confirmed by scanning electron mi-
croscopy (SEM) using a Nova Nanolab 600 Dualbeam
(FEI, Eindhoven, the Netherlands) (Figure 1). In addition,
the gravimetric mass concentration was determined. ASartorius MC-5 microbalance (Sartorius, Goettingen,
Germany) was used in controlled relative humidity (40 –
45%) and temperature (21 – 23°C) conditions to do the
mass measurements, the filters were weighed before and
after each exposure. Laboratory and field blanks were used
for quality assurance. The filter volume flow was mea-
sured with dry gas meters (Gallus 2000 G1.6, Actaris
Meterfabriek B.V., Dordrecht, the Netherlands).
Animals
The Animal Ethical Committee of the National Institute
for Public Health and the Environment (Bilthoven, the
Netherlands) approved the experimental design of the
animal study at the 6th of July 2012. Healthy male
Fischer rats (F344/DuCrl) were supplied by Charles River
(Sulzfeld, Germany). The animals were kept under specific
pathogen free (SPF) conditions. After an acclimatization
period of two weeks, the animals were 10 weeks old at the
start of the experiment. The rats were randomly allocated
to the control and the test groups. During exposure, the
animals were restrained in nose-only tubes (CH technolo-
gies, Westwood NJ, USA) fixed to the inhalation system.
Figure 11 Spray nozzle setup for the nose-only exposure to 410 nm silver particles. The silver particles are in solution and sprayed into a
heated mixing chamber. Subsequently, the particles are dried in an oven and mixed with compressed air. Particle size, number and mass are
continuously monitored.
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in macrolon III cages with filtertops to prevent dust enter-
ing the cages (bedding material: Lignocel S8-15, Altromin
Spezialfutter GmbH & Co. KG). The animal room was
air-conditioned with a 12 hours light- 12 hours dark cycle,
the temperature ranging from 20 to 24°C with relative hu-
midity ranging from 30 – 70%. Except during exposure,
certified feed CRM (SDS Diets, UK) and water were avail-
able ad libitum. Before start of the exposure period, all
animals were acclimatized to the nose only tubes on 3
consecutive days for 1 hour per day. At 24 hours and
7 days after the last exposure, rats were weighed, anesthe-
tized by a single intraperitoneal injection of ketamine
(75 mg/kg) and xylazine (10 mg/kg) and subsequently ex-
sanguinated via the abdominal aorta.Experimental design
The rats were nose-only exposed for 6 hours per day, 4
consecutive days to fresh air, 15 nm silver nanoparticles
or 410 nm silver nanoparticles, 12 rats per exposure
group. Of each exposure group, 6 rats were sacrificed
24 hours after exposure and the other 6 rats were sacri-
ficed 7 days after exposure. During nose-only inhalation,
rats have a breathing pattern that results in a more real-
istic internal exposure than a single high dose in intra-
tracheal instillation and oropharyngeal aspiration or
possible additional oral exposure in whole-body expos-
ure chambers.Quantification of silver in tissues by high resolution
inductively coupled plasma mass spectrometry (HR-ICP-MS)
The presence of silver in the lungs, liver, spleen, kidneys,
brain, testis and lung associated lymph nodes was deter-
mined by high resolution inductively coupled plasma
mass spectrometer (HR-ICP-MS) [53,54]. Samples of ho-
mogenized tissue (max. 0.5 g) were completely dissolved
on a block heater (Stuart SBH200D, supplied by Omni-
labo, Breda, The Netherlands) for 24 hours at 120°C
after the direct addition of aqua regia (0.5 mL 60% nitric
acid, ultrapure, and 1.5 mL 30% hydrochloric acid, ultra-
pure) and afterwards diluted. The silver concentration in
the digests was determined using high resolution induct-
ively coupled plasma mass spectroscopy (HR-ICPMS;
Element XR, Thermo Fisher Scientific, Bremen, Germany).
Both silver isotopes (107Ag and 109Ag) were measured in
the low-resolution mode. External calibration curves of the
interference-free silver isotopes were used for quantifica-
tion. On-line addition and correction with an internal
standard (rhodium with the measured isotope 103Rh in the
low-resolution mode) was applied too. The results of 107Ag
were reported and the results of 109Ag were used for con-
trol. Sample pre-treatment and analysis were carried out in
a cleanroom facility class 100 000.
Estimated deposited dose in lungs using Multi Path
Particle Dosimetry model (MPPD model)
To estimate the fractions of deposited dose in the head,
tracheobronchial, and alveolar region of the rats, the
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was used [16]. We used the default parameters of the
model for rats, i.e., a forced respiratory capacity of 4 ml,
head volume of 0.42 ml, nasal breathing, tidal volume of
2.1 ml, and a breathing frequency of 102/min. The in-
spiratory fraction was 0.5, and no pause was entered.
Calculations were done using the count median diam-
eter (CMD), geometric SD, the mass concentration, and
a density of 10.49 g/cm3.
Electron microscopy of the lung
Of two animals of each group, the left lung was cut out
with the bronchus attached and fixed by pressure (2 kPa
for 1 hour) with half-strength Karnovsky fixative (0.08 M
Sodium-cacodylate buffer, 2.5% glutaraldehyde, 0.025 mM
CaCl2, 0.05 mM MgCl2) for electron microscopy. After
two days, the fixative was replaced with 2% para-
formaldehyde in sodium-cacodylate buffer for storage. Of
each lung, three slices of about 1 – 1.5 mm were cut out
at the top, middle and bottom of the lung for further ana-
lysis. The tissue slices were post-fixed by osmium potas-
sium ferro-cyanide solution (0.1 M sodium-cacodylate
buffer, 1% osmium tetra-oxide, 1.5% potassium ferro-
cyanide). Next, the tissue slices were dehydrated in aceton
series, cut in smaller pieces and subsequently embedded
in epon. The epon was polymerized at 60°C. The epon
blocks were trimmed prior to sectioning. During section-
ing, ultrathin sections of 70 nm were sectioned and put
on 3 mm hexagonal copper grids coated with a formvar-
film. The sections were analysed by transmission electron
microscopy (TEM) (Tecnai 10, 100 kV, FEI, Eindhoven,
the Netherlands).
Silver enhancement
A silver enhancement procedure was used to increase the
particle size of the silver nanoparticles in the lung tissue to
make it possible to detect the silver nanoparticles with elec-
tron microscopy. The silver enhancement reagents were
purchased at Aurion and performed on grid according to
manufacturer’s instructions (Wageningen, the Netherlands).
Clinical examinations
The animals were examined three times on exposure
days (before, during and after exposure) and once daily
during the periods before and after exposure. The clin-
ical examination included examination of attitude, ani-
mal fur, activity level, food and water intake, and faeces
and urine production. The body weight of the animals
was determined upon arrival, at the start of the exposure
period and at the day of sacrifice.
Hematology analysis
Blood samples were collected in EDTA-containing tubes
and in citrate vials for analysis of cell types andinflammatory markers in the blood. The level of Fibrino-
gen in the citrate plasma was measured using a rat
Fribrinogen ELISA kit (GenWay Biotech, Inc., San Diego,
USA) according to manufacturer’s instructions.
Histopathology
The lungs fixed with half-strength Karnovsky fixative
were also used for histopathology. Of these lungs a thin
slice was made over the length of the tissue, embedded
in paraffin and stained by haematoxylin-eosin for histo-
pathology analysis.
Bronchoalveolar lavage fluid (BALF) analysis
The left lung of the rats was bound just below the bifur-
cation of the trachea and the right lung was cannulated
via the trachea. Bronchoalvelar lavage was performed in
situ by infusing the right lung three times with 27 ml/kg
physiological saline. The retrieved bronchoalveolar lav-
age fluid (BALF) was kept on ice and centrifuged for
10 minutes at 400 g. The pellet was resuspended in
physiological salt for analysis of the total cell number
and cell differentials. Cytospin preparations were stained
and evaluated microscopically for macrophages, poly-
nuclear macrophages, polymorph nuclear neutrophils,
lymphocytes, monocytes, eosinophils, and atypical cells.
At least 400 cells were counted on each slide. The cell-
free supernatant was collected to assess cell damage by
measurement of total protein content and the release of
lactate dehydrogenase (LDH) by Beckman Coulter auto-
analyser Synchron LX20 (Beckman Coulter, Inc.) and to
assess the induction of pro-inflammatory cytokines. The
remainder of the supernatant was stored at −80°C.
Measurement of pro-inflammatory cytokines
The presence of pro-inflammatory cytokines IL-1beta,
IL-6, TNF-alfa, IFN-gamma, IL-13, GM-CSF, MCP-1, IL-
12p70, IL-18, MIP-1a, MIP-2 and RANTES in the super-
natant of the BALF was measured by a Bio-Plex Pro
assay for rat cytokines according to manufacturer’s in-
structions (Bio-Rad Laboratories, Inc.).
Measurement of oxidative stress
The induction of oxidative stress was determined by
measuring the amount of reduced, oxidized and total
glutathione in the lungs. The rinsed right lung was ho-
mogenized on ice in 4 ml of Phosphate/EDTA buffer
(pH 7.5). Subsequently, the homogenate was centrifuged
at 600 g for 10 minutes. To remove the proteins from
the samples, the supernatant was mixed 1:1 with meta-
phosphorid acid, incubated for 15 minutes on ice, and
centrifuged at 4000 rpm for 10 minutes. The amount of
reduced, oxidized and total glutathione was measured by
Beckmann Coulter Autoanalyser in the supernatant.
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The raw data of the BALF was corrected for retrieved
fluid. To compare the different exposure groups, the
data was analysed by the Kruskal Wallis nonparametric
test (Graphpad Prism). Statistical significance is indi-
cated with a * (p = < 0.05). In all graphs, error bars rep-
resent the standard deviation of the mean.
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Additional file 1: Figure S1. SMPS and OPS particle size distribution
(left) and CPC particle number concentration (right) of 15 nm and 410
nm silver particles.
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